423 related articles for article (PubMed ID: 19029125)
1. Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials.
Antoniades C; Antonopoulos AS; Tousoulis D; Marinou K; Stefanadis C
Eur Heart J; 2009 Jan; 30(1):6-15. PubMed ID: 19029125
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.
B-Vitamin Treatment Trialists' Collaboration
Am Heart J; 2006 Feb; 151(2):282-7. PubMed ID: 16442889
[TBL] [Abstract][Full Text] [Related]
3. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine-lowering trials for prevention of heart disease and stroke.
Clarke R
Semin Vasc Med; 2005 May; 5(2):215-22. PubMed ID: 16047274
[TBL] [Abstract][Full Text] [Related]
5. [Vitamin treatments that lower homocysteine concentration: can they decrease cerebrovascular disease in primary prevention?].
Méndez-González J; Rodríguez-Millán E; Julve J; Blanco-Vaca F
Rev Neurol; 2010 Feb 16-28; 50(4):235-44. PubMed ID: 20198596
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine, B-vitamins and CVD.
McNulty H; Pentieva K; Hoey L; Ward M
Proc Nutr Soc; 2008 May; 67(2):232-7. PubMed ID: 18412997
[TBL] [Abstract][Full Text] [Related]
7. Serum homocysteine, folate, vitamin B12 levels and arterial stiffness in diabetic patients: which of them is really important in atherogenesis?
Shargorodsky M; Boaz M; Pasternak S; Hanah R; Matas Z; Fux A; Beigel Y; Mashavi M
Diabetes Metab Res Rev; 2009 Jan; 25(1):70-5. PubMed ID: 19065546
[TBL] [Abstract][Full Text] [Related]
8. [Homocysteine and cardiovascular risk].
Auer J; Berent R; Weber T; Lassnig E; Eber B
Wien Med Wochenschr; 2001; 151(1-2):25-8. PubMed ID: 11234594
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients.
Suliman ME; Lindholm B; Bárány P; Qureshi AR; Stenvinkel P
Semin Dial; 2007; 20(6):523-9. PubMed ID: 17991198
[TBL] [Abstract][Full Text] [Related]
10. Vitamins and stroke: the homocysteine hypothesis still in doubt.
Ntaios GC; Savopoulos CG; Chatzinikolaou AC; Kaiafa GD; Hatzitolios A
Neurologist; 2008 Jan; 14(1):2-4. PubMed ID: 18195649
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine and vitamin therapy in stroke prevention and treatment: a review.
Manolescu BN; Oprea E; Farcasanu IC; Berteanu M; Cercasov C
Acta Biochim Pol; 2010; 57(4):467-77. PubMed ID: 21140003
[TBL] [Abstract][Full Text] [Related]
12. Effect of folate supplementation on serum homocysteine and plasma total antioxidant capacity in hypercholesterolemic adults under lovastatin treatment: a double-blind randomized controlled clinical trial.
Shidfar F; Homayounfar R; Fereshtehnejad SM; Kalani A
Arch Med Res; 2009 Jul; 40(5):380-6. PubMed ID: 19766902
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine, folic acid and coronary artery disease: possible impact on prognosis and therapy.
Djuric D; Jakovljevic V; Rasic-Markovic A; Djuric A; Stanojlovic O
Indian J Chest Dis Allied Sci; 2008; 50(1):39-48. PubMed ID: 18610689
[TBL] [Abstract][Full Text] [Related]
14. Impact of homocysteine-lowering vitamin therapy on long-term outcome of patients with coronary artery disease.
Mager A; Orvin K; Koren-Morag N; Lev IE; Assali A; Kornowski R; Shohat M; Battler A; Hasdai D
Am J Cardiol; 2009 Sep; 104(6):745-9. PubMed ID: 19733705
[TBL] [Abstract][Full Text] [Related]
15. Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases?
Debreceni B; Debreceni L
Cardiovasc Ther; 2012 Aug; 30(4):227-33. PubMed ID: 21884001
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine, folic acid, B vitamins and cardiovascular risk.
Blacher J; Safar ME
J Nutr Health Aging; 2001; 5(3):196-9. PubMed ID: 11458292
[TBL] [Abstract][Full Text] [Related]
17. [Plasma homocysteine levels in Spanish patients with coronary artery disease].
Domínguez Rodríguez A; Abreu González P; Jiménez Sosa A; García González MJ; Barragán Acea A; de Armas Trujillo D
An Med Interna; 2002 Apr; 19(4):166-70. PubMed ID: 12090055
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
Heinz J; Kropf S; Luley C; Dierkes J
Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine in the prevention of ischemic heart disease, stroke and venous thromboembolism: therapeutic target or just another distraction?
Lonn E
Curr Opin Hematol; 2007 Sep; 14(5):481-7. PubMed ID: 17934354
[TBL] [Abstract][Full Text] [Related]
20. Is plasma homocysteine a modifiable risk factor for stroke?
Hankey GJ
Nat Clin Pract Neurol; 2006 Jan; 2(1):26-33. PubMed ID: 16932518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
